Goldman Sachs Asks 'Is Curing Patients A Sustainable Business Model?'
April 12th 2018

CBS Local - Investment banking giant Goldman Sachs is reportedly asking some very cold questions about the healthcare industry and whether it's a good business move to cure diseases.

In an April 10 financial report titled "The Genome Revolution," company analysts allegedly posed the question "is curing patients a sustainable business model?" The report broke down the pros and cons of new gene therapy treatments being worked on by biotech companies. Turning the search for medical remedies into a numbers game, analyst Salveen Richter called potential "one shot cures" a bad business decision that will hurt a company's bottom line.

"While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow," Richter said, via Yahoo Finance.
Goldman researchers pointed to pharmaceutical company Gilead Sciences, which developed a treatment for hepatitis C, as an example of the financial impact treating diseases can have on profits. "In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients," the memo argued.

Gilead Sciences' 90 percent cure rate of hepatitis C will reportedly send its sales plunging from $12.5 billion in 2015 to less than $4 billion this year. The Goldman Sachs report allegedly suggests that biotech firms move to developing treatments for conditions with larger patient pools such as spinal muscular atrophy and hemophilia.

Richter and Goldman Sachs have not commented on the report.


To go back, click on the back arrow, top left-hand corner
Disclaimer: Throughout this website, statements are made pertaining to the properties and/or functions of food and/or nutritional products. The information provided is for educational purposes only and is not intended as medical advice. Users assume all responsibility for the application of the content on themselves. These statements have not been evaluated by the Food and Drug Administration and these materials and products are not intended to diagnose, treat, cure or prevent any disease. The information and/or products on this website are reproduced are not meant to replace and/or to ignore the advice of a practicing physician.

This website, HELPING CANCER VICTIMS, is NOT a 501(c)(3) enterprise. Your support makes it possible for every visitor to recognize there may be an alternative to your well-being. Supporting this mission may save lives. I am trying to spread the truth about cancer, as I see it (non-doctor). Your generous donation will help me to continue this research and expose the truth, as I see it; cancer is not a death sentence, is reversible and or preventable with the right knowledge / information. There is no money available for the prevention of cancer, only for a cure after the fact. If everyone that visits donates one-dollar ($1.00) could save a life by supporting this website, with its alternative view point. What is one life worth? Conventional cancer treatment may cost an individual between $200,000.00 - $1,000,000.00. Most people can afford to pay for the alternatives found on this website that is why (in my opinion) most of these alternative treatments are considered quackery by the FDA and the AMA. Furthermore, none of the remedies discussed herein involve expensive patented pharmaceuticals that have never cured any disease, not one, ever. Come back and visit often, I am just getting started… John Korman (561) 372-5218, please leave a message and I will return your call within 24 hours.